Skip to content

Clinical trials

Diarrhea trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diarrhea Clear all

699 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20012
200211
20037
200418
200523
200623
200725
200825
200936
201049
201128
201243
201337
201438
201534
201629
201726
201832
201936
202018
202128
202217
202326
202421
202520
202621

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed475
Unknown status83
Terminated55
Recruiting29
Withdrawn20
Not yet recruiting15
Active, not recruiting14
Enrolling by invitation6
Suspended2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
London School of Hygiene and Tropical Medicine16
International Centre for Diarrhoeal Disease Research, Bangladesh14
Bausch Health Americas, Inc.11
Johns Hopkins Bloomberg School of Public Health10
Centers for Disease Control and Prevention9
PATH9
Mayo Clinic8
Society for Applied Studies8
International Vaccine Institute7
Medical University of Warsaw7

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diarrhea699
Irritable Bowel Syndrome66
Constipation58
Abdominal Pain55
Pneumonia34
Gastroenteritis33
Clostridium Infections32
Malaria25
Malnutrition25
Vomiting23

Trials

Showing 26 to 50 of 699. Each trial links to its page on Pharma Observatory.

599 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.